Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: Evidence of their presence in atherosclerotic lesions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 467-477

  Ravandi, Amir ^a,b   Kuksis, Arnis ^b   Shaikh, Nisar A ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Spectral Diagnostics Inc   (Canada)

Author keywords

Atheroma; Diabetes; Glycation, phospholipid; Low density lipoproteins; Peroxidation, lipid

Indexed keywords

ALDEHYDE; CHOLESTEROL ESTER; COPPER; GLUCOSE; GLYCEROPHOSPHOETHANOLAMINE; HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHEMICAL REACTION; CONTROLLED STUDY; GLYCATION; HUMAN; HUMAN TISSUE; LIPID OXIDATION; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0033951646     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.2.467     Document Type: Article

References (44)

1. Ross R. The pathogenesis of atherosclerosis. Nature. 1992;362:801-809.
2. Lyons T J, Jenkins AJ. Lipoprotein glycation and its metabolic consequences. Curr Opin Lipidol. 1997;8:174-180.
3. Monnier VM. In: Baynes JW, Monnier VM, eds. The Maillard Reaction in Aging, Diabetes, and Nutrition. New York, NY: Alan R. Liss; 1989;1-22.
4. Witztum J L, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 1982;31:283-291.
5. Sobenin IA, Tertov VV, Koschinsky T, Bunting CE, Slavina ES, Dedov II, Orekhov AN. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis. 1993; 100:41-54.
6. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A. 1993;90:6434-6438.
7. Gugliucci A, Menini T, Stahl AJ. Susceptibility to copper-enhanced autoxidation of VLDL+LDL fractions from diabetic patients. Biochem Mol Biol Int. 1994;32:139-147.
8. Kobayashi K, Watanabe J, Umeda F, Nawata H. Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocrinol J. 1995;42: 461-465.
9. Hunt JV, Bottoms MA, Clare K, Skamarauskas JT, Mitchinson MJ. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis Biochem J. 1994; 300:243-249.
10. Ravandi A, Kuksis A, Marai L, Myher JJ. Preparation and characterization of glucosylated aminoglycerophospholipids. Lipids. 1995;30:885-891.
11. Ravandi A, Kuksis A, Marai L, Myher JJ, Steiner G, Lewis G, Kamido H. Isolation and identification of glycated aminophospholipids from red cell and plasma of diabetic blood. FEBS Lett. 1996;381:77-81.
12. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipid from animal tissues. J Biol Chem. 1957;226:497-509.
13. Kremer JM, Esker MW, Pathmamanoharan C, Wiersema PH. Vesicles of variable diameter prepared by a modified injection method. Biochemistry. 1977;16:3932-3935.
14. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
15. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
16. Engelmann B, kogl C, Kulschar R, Schaipp B. Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets. Biochem J. 1996;315:781-789.
17. Deleted in proof.
18. Kamido H, Nonaka K, Kuksis A, Marai L, Ravandi A. Identification of lipid ester core aldehydes and hydroperoxides in atherosclerotic lesions. Circulation. 1997:94(suppl I):I-707. Abstract.
19. Shaikh NA. Assessment of various techniques for the quantitative extraction of lysophospholipids from myocardial tissues. Anal Biochem. 1994;216:313-321.
20. Ravandi A, Kuksis A, Myher JJ, Marai L. Determination of lipid ester ozonides and core aldehydes by high-performance liquid chromatography with on-line mass spectrometry. J Biochem Biophys Methods. 1995;30:271-285.
21. Yang LY, Kuksis A, Myher JJ. Intestinal absorption of menhaden and rapeseed oils and their fatty acid methyl and ethyl esters in the rat. Biochem Cell Biol. 1990;68:480-491.
22. Becart J, Chevalier C, Biese JP. Quantitative analysis of phospholipids by HPLC with a light scattering evaporating detector: application to raw materials of cosmetic use. J High Resol Chromatogr. 1990;10:126-129.
23. Ravandi A, Kuksis A, Shaikh NA, Jackowski G. Preparation of Schiff base adducts of phosphatidylcholine core aldehydes and aminophospholipids, amino acids and myoglobin. Lipids. 1997;32:989-1001.
24. Lederer MO, Drisbusch CM, Bundschuh RM. Amadori products from model reactions of D-glucose with phosphatidyl ethanolamine: independent synthesis and identification of 1-deoxy-1-(2-hydroxyethylamino)-D-fructose derivatives Carbohydr Res. 1997;301:111-121.
25. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci U S A. 1994;91:9441-9445.
26. Requena JR, Ahmed MU, Fountain CW, Degenhardt TP, Reddy S, Perez C, Lyons TJ, Jenkins AJ, Baynes JW, Thorpe SR. Carboxymethylethanolamine, a biomarker of phospholipid modification during the Maillard reaction in vivo. J Biol Chem. 1997;272:17473-17479.
27. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R. Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science. 1992;258:651-653.
28. Pamplona R, Bellmunt MJ, Portero M, Riba D, Prat J. Chromatographic evidence for Amadori product formation in rat liver aminophospholipids. Life Sci. 1995;57:873-879.
29. Hofner G, Lichtenberg D, Kostner GM, Hermetter A. Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: alkenylacyl subclass are preferred targets. Clin Biochem. 1996;29:45-50.
30. Reiss D, Beyer K, Engelmann B. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem J. 1997;323:807-814.
31. Myher JJ, Kuksis A, Pind S. Molecular species of glycerophospholipids and sphingomyelins of human plasma: comparison to red blood cells. Lipids. 1989;24:408-418.
32. Felde R, Spiteller G. Plasmalogen oxidation in human serum lipoproteins. Chem Phys Lipids. 1995;76:259-267.
33. Rabini RA, Firretti G, Galassi R, Taus M, Curatola G, Tangorra A, Fumelli P, Mazzanti L. Modified fluidity and lipid composition in lipoproteins and platelets membranes from diabetic individuals. Clin Biochem. 1994;27:381-385.
34. Hunt JV, Wolff SP. Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic Res Commun. 1991: 12-13(pt 1):115-123.
35. Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J. 1993;291:529-535.
36. Greenspan P, Ryu BH, Mao F, Gutman RL. Association of negatively-charged phospholipids with low-density lipoprotein (LDL) increases its uptake and the deposition of cholesteryl-esters by macrophages. Biochim Biophys Acta. 1995;1257:257-264.
37. Ravandi A, Kuksis A, Shaikh NA. Glycated lipid moiety of low-density lipoprotein promotes macrophage uptake and accumulation of cholesteryl ester and triacylglycerol. J Biol Chem. 1999;274:16494-16500.
38. Hunt JV, Skamarauskas JT, Mitchinson MJ. Protein glycation and fluorescent material in human atheroma. Atherosclerosis. 1994;111:255-265.
39. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, Bucala R. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Physiol. 1993;143:1649-1656.
40. Kamido H, Kuksis A, Marai L, Myher J. Lipid ester-bound aldehydes among copper-catalyzed peroxidation products of human plasma lipoproteins. J Lipid Res. 1995;36:1876-1886.
41. Stitt AW, He C, Friedman S, Scher L, Rossi P, Ong L, Founds H, Li YM, Bucala R, Vlassara H. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med. 1997;3:617-627.
42. Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597-13607.
43. Stremler KE, Stafforini DM, Prescott SM, McIntyre TM. Human plasma platelet-activating factor acetylhydrolase: oxidatively fragmented phospholipids as substrates. J Biol Chem. 1991;266:11095-11103.
44. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322-2330.